| 刘炫,宋华琳.药品管理法律责任的制度创新[J].中国药事,2019,33(11):1212-1216 |
| 药品管理法律责任的制度创新 |
| The Institutional Innovation of Legal Liability in the Drug Administration Law |
| 投稿时间：2019-10-19 |
| DOI：10.16153/j.1002-7777.2019.11.002 |
| 中文关键词: 药品管理法 法律责任 行政处罚 |
| 英文关键词: the Drug Administration Law legal liability administrative penalty |
| 基金项目:国家社会科学基金2017年年度项目“合作规制的行政法研究”（编号17BFX004） |
|
| 摘要点击次数: 1193 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：评析2019年版《药品管理法》中的法律责任制度的创新，明确药品市场主体的主体责任和药品监管者的监管责任，以期减少药品违法事件的发生，保证公众用药安全。方法：对比2001年版《药品管理法》，结合行政法原理，加之比较法的视角，对2019年版《药品管理法》进行解析。结果与结论：2019年版《药品管理法》强化了法律责任的重要性，设定了更为严格的法律责任，通过体系化的制度设计和完善的法律责任机制，提高了违法者的违法成本，有助于遏制和惩戒违法行为。 |
| 英文摘要: |
| Objective:To analyze the innovation of the legal liability system in the Drug Administration Law (2019 edition), clarify the main liability of drug market subjects and the regulatory liability of drug regulators, in order to reduce the occurrence of drug violations and ensure the safety of public drug use. Methods:The Drug Administration Law (2019 edition) was analyzed by comparing with the Drug Administration Law (2011 edition) based on the principles of administration law and the comparison method. Results and Conclusion:The Drug Administration Law (2019 edition) strengthens the importance of legal liability, sets up more rigorous legal liability, and raises the cost of lawbreaking through systematic institutional design and perfect legal liability mechanism, which helps to curb and punish illegal behaviors. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |